The effectiveness of two doses of Hecolin vaccine in response to outbreaks in resource-limited settings

Abstract

References

1. Devarbhavi, H., Asrani, S. K., Arab, J. P., Nartey, Y. A., Pose, E. & Kamath, P. S. 2023. Global burden of liver disease: 2023 update. J Hepatol, 79, 516-537.
   

2. Nesbitt, R. C., Azman, A. S., Asilaza, V. K., Edwards, J. K., Gitahi, P., Nkemenang, P., Duncker, J., Haile, M., Gakima, P., Wamala, J. F., Loro, F. B., Biem, D., Staderini, N., Albela, M., Rull, M., Rumunu, J., Ciglenecki, I. & Gignoux, E. 2024. Safety of hepatitis E vaccine in pregnancy: an emulated target trial following a mass reactive vaccination campaign in Bentiu internally displaced persons camp, South Sudan. Lancet Glob Health, 12, e1881-e1890.
   

3. Nesbitt, R. C., Kinya asilaza, V., Alvarez, C., Gitahi, P., Nkemenang, P., Duncker, J., Haile, M., Gakima, P., Wamala, J. F., Loro, F. B., Koyuncu, A., Biem, D., Albela, M., Rull, M., Gignoux, E., Rumunu, J., Eckerle, I., Ciglenecki, I. & Azman, A. S. 2025. The effectiveness of two doses of recombinant hepatitis E vaccine in response to an outbreak in Bentiu, South Sudan: a case-control and bias indicator study. Lancet Infect Dis, 25, 537-547.
   

4. Peron, J. M., Larrue, H., Izopet, J. & Buti, M. 2023. The pressing need for a global HEV vaccine. J Hepatol, 79, 876-880.
   

5. WHO. Highlights from the Meeting of the Strategic Advisory Group of Experts (SAGE) on Immunization, March 11-13, 2024, https://www.who.int/publications/m/item/highlights-from-the-meeting-of-thestrategic-advisory-group-of-experts-(sage)-on-immunization-11-13-march-2024.
   

6. Zhang, F., Shi, Z., Wu, Y., Xia, J. & Wang, L. 2025. Immunogenicity and Efficacy of an Accelerated Vaccination Schedule Against Hepatitis E Virus Infection in Rabbits. J Med Virol, 97, e70218.
   

7. Zhang, F., Wang, J., Cheng, J., Zhang, X., He, Q., Zhaochao, L., Shu, J., Yan, L., WANG, L., WANG, L. & ZHANG, J. 2022. Clinical features of sporadic hepatitis E virus infection in pregnant women in Shanghai, China. J Infect, 84, 64-70.
   

8. Zhang, F., Yang, Z., Dai, C., He, Q., Liang, Z., Liu, T., Huang, W., Wang, Y., Wang, L. & WANG, L. 2023. Efficacy of an accelerated vaccination schedule against hepatitis E virus infection in pregnant rabbits. J Med Virol, 95, e28193.
   

9. Zhang, Y., Zeng, H., Liu, P., Liu, L., Xia, J., Wang, L., Zou, Q., Wang, L. & Zhuang, H. 2015. Hepatitis E vaccine immunization for rabbits to prevent animal HEV infection and zoonotic transmission. Vaccine, 33, 4922-4928.
   

10. Zhu, F. C., Zhang, J., Zhang, X. F., Zhou, C., Wang, Z. Z., Huang, S. J., Wang, H., Yang, C. L., Jiang, H. M., Cai, J. P., Wang, Y. J., Ai, X., Hu, Y. M., Tang, Q., Yao, X., Yan, Q., Xian, Y. L., Wu, T., Li, Y. M., Miao, J., Ng, M. H., Shih, J. W. & Xia, N. S. 2010. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet, 376, 895-902.
    

Proportional views